⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
PFE
SNY
TSEM
JNJ
LLY
MRK
BMY
ABBV
GILD
CRSP
NKTR
INCY
Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer
globenewswire.com
NKTR
AMGN
MRK
INGN
ILMN
REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata
prnewswire.com
NKTR
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025
prnewswire.com
NKTR
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
NKTR
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
globenewswire.com
ADAR
NKTR
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
globenewswire.com
MRK
AZN
CRSP
BGNE
NKTR
ALKS
XNNY
BMY
New Data from REZOLVE-AD Study of Rezpegaldesleukin Presented in Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
prnewswire.com
NKTR
Nektar Therapeutics Reports Third Quarter 2025 Financial Results
prnewswire.com
NKTR
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
prnewswire.com
NKTR